ZA9710587B - Dimesylate salts of neuropeptide y ligands - Google Patents
Dimesylate salts of neuropeptide y ligandsInfo
- Publication number
- ZA9710587B ZA9710587B ZA9710587A ZA9710587A ZA9710587B ZA 9710587 B ZA9710587 B ZA 9710587B ZA 9710587 A ZA9710587 A ZA 9710587A ZA 9710587 A ZA9710587 A ZA 9710587A ZA 9710587 B ZA9710587 B ZA 9710587B
- Authority
- ZA
- South Africa
- Prior art keywords
- neuropeptide
- ligands
- dimesylate
- salts
- dimesylate salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3181596P | 1996-11-26 | 1996-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9710587B true ZA9710587B (en) | 1999-05-25 |
Family
ID=21861551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9710587A ZA9710587B (en) | 1996-11-26 | 1997-11-25 | Dimesylate salts of neuropeptide y ligands |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5914329A (xx) |
| EP (1) | EP0944611B1 (xx) |
| JP (1) | JP3120861B2 (xx) |
| AP (1) | AP9701148A0 (xx) |
| AR (1) | AR010304A1 (xx) |
| AT (1) | ATE257472T1 (xx) |
| AU (1) | AU4792497A (xx) |
| BR (1) | BR9713538A (xx) |
| CA (1) | CA2272927C (xx) |
| DE (1) | DE69727155T2 (xx) |
| DK (1) | DK0944611T3 (xx) |
| ES (1) | ES2213207T3 (xx) |
| GT (1) | GT199700123A (xx) |
| HN (1) | HN1997000154A (xx) |
| HR (1) | HRP970640A2 (xx) |
| ID (1) | ID18964A (xx) |
| MA (1) | MA26450A1 (xx) |
| PA (1) | PA8441701A1 (xx) |
| PE (1) | PE17099A1 (xx) |
| PT (1) | PT944611E (xx) |
| TN (1) | TNSN97191A1 (xx) |
| WO (1) | WO1998023603A1 (xx) |
| ZA (1) | ZA9710587B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001232900A1 (en) * | 2000-01-20 | 2001-07-31 | Michael Amling | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| JP2005516001A (ja) | 2001-12-05 | 2005-06-02 | ベイラー カレッジ オブ メディスン | 交感神経活動状態の調節による骨形成の制御のための方法及び組成物 |
| WO2003057886A2 (en) | 2002-01-09 | 2003-07-17 | Arexis Ab | Detection of mutations |
| US20070254930A1 (en) * | 2004-11-23 | 2007-11-01 | Dong Wha Pharm. Ind. Co., Ltd. | Oral Preparation Having Improved Bioavailability |
| AU2006235200A1 (en) * | 2005-04-15 | 2006-10-19 | Regenertech Pty Limited | Use of Neuropeptide Y (NPY) and agonists and antagonists thereof for tissue regeneration |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692977B2 (en) * | 1994-11-07 | 1998-06-18 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands |
-
1997
- 1997-11-18 PA PA19978441701A patent/PA8441701A1/es unknown
- 1997-11-18 US US08/972,470 patent/US5914329A/en not_active Expired - Fee Related
- 1997-11-19 DE DE69727155T patent/DE69727155T2/de not_active Expired - Fee Related
- 1997-11-19 PT PT97910602T patent/PT944611E/pt unknown
- 1997-11-19 CA CA002272927A patent/CA2272927C/en not_active Expired - Fee Related
- 1997-11-19 PE PE1997001052A patent/PE17099A1/es not_active Application Discontinuation
- 1997-11-19 ES ES97910602T patent/ES2213207T3/es not_active Expired - Lifetime
- 1997-11-19 WO PCT/IB1997/001465 patent/WO1998023603A1/en active IP Right Grant
- 1997-11-19 BR BR9713538A patent/BR9713538A/pt not_active Application Discontinuation
- 1997-11-19 JP JP10524469A patent/JP3120861B2/ja not_active Expired - Fee Related
- 1997-11-19 EP EP97910602A patent/EP0944611B1/en not_active Expired - Lifetime
- 1997-11-19 AU AU47924/97A patent/AU4792497A/en not_active Abandoned
- 1997-11-19 DK DK97910602T patent/DK0944611T3/da active
- 1997-11-19 AT AT97910602T patent/ATE257472T1/de not_active IP Right Cessation
- 1997-11-20 AP APAP/P/1997/001148A patent/AP9701148A0/en unknown
- 1997-11-24 AR ARP970105494A patent/AR010304A1/es unknown
- 1997-11-25 ZA ZA9710587A patent/ZA9710587B/xx unknown
- 1997-11-25 TN TNTNSN97191A patent/TNSN97191A1/fr unknown
- 1997-11-25 GT GT199700123A patent/GT199700123A/es unknown
- 1997-11-25 MA MA24872A patent/MA26450A1/fr unknown
- 1997-11-25 ID IDP973762A patent/ID18964A/id unknown
- 1997-11-26 HN HN1997000154A patent/HN1997000154A/es unknown
- 1997-11-26 HR HR60/031,815A patent/HRP970640A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA26450A1 (fr) | 2004-12-20 |
| TNSN97191A1 (fr) | 2005-03-15 |
| PE17099A1 (es) | 1999-02-19 |
| ES2213207T3 (es) | 2004-08-16 |
| PA8441701A1 (es) | 2000-05-24 |
| JP2000505110A (ja) | 2000-04-25 |
| DK0944611T3 (da) | 2004-04-13 |
| BR9713538A (xx) | 2000-03-21 |
| AU4792497A (en) | 1998-06-22 |
| ID18964A (id) | 1998-05-28 |
| GT199700123A (es) | 1999-05-19 |
| HN1997000154A (es) | 1999-02-09 |
| JP3120861B2 (ja) | 2000-12-25 |
| WO1998023603A1 (en) | 1998-06-04 |
| DE69727155T2 (de) | 2004-07-08 |
| EP0944611A1 (en) | 1999-09-29 |
| DE69727155D1 (de) | 2004-02-12 |
| ATE257472T1 (de) | 2004-01-15 |
| CA2272927A1 (en) | 1998-06-04 |
| AR010304A1 (es) | 2000-06-07 |
| HRP970640A2 (en) | 1998-10-31 |
| AP9701148A0 (en) | 1998-01-31 |
| US5914329A (en) | 1999-06-22 |
| PT944611E (pt) | 2004-04-30 |
| EP0944611B1 (en) | 2004-01-07 |
| CA2272927C (en) | 2003-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9602294D0 (en) | Heterocyclic compounds | |
| GB9617305D0 (en) | Heterocyclic compounds | |
| GB9408872D0 (en) | Heterocyclic compounds | |
| ZA9710587B (en) | Dimesylate salts of neuropeptide y ligands | |
| GB9413758D0 (en) | Heterocyclic compounds | |
| GB9401921D0 (en) | Heterocyclic compounds | |
| GB9401994D0 (en) | Heterocyclic compounds | |
| EP0900204A4 (en) | HETEROCYCLIC CONNECTIONS | |
| GB9504448D0 (en) | Heterocyclic compounds | |
| EP0900219A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0900217A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0912183A4 (en) | HETEROCYCLIC COMPOSITIONS | |
| EG20790A (en) | Heterocyclic compounds | |
| GB9404721D0 (en) | Heterocyclic compounds | |
| GB9424260D0 (en) | Heterocyclic compounds | |
| GB9419083D0 (en) | Heterocyclic compounds | |
| GB9426455D0 (en) | Heterocyclic compounds | |
| ZA9531B (en) | Heterocyclic compounds | |
| GB9404720D0 (en) | Heterocyclic compounds | |
| GB9404719D0 (en) | Heterocyclic compounds | |
| GB9420700D0 (en) | Heterocyclic compounds | |
| GB9422404D0 (en) | Heterocyclic compounds | |
| GB9419342D0 (en) | Heterocyclic compounds | |
| GB9419085D0 (en) | Heterocyclic compounds | |
| GB9404734D0 (en) | Heterocyclic compounds |